Overview
Title: Transformative Microsystems for Cancer Diagnosis, Treatment Monitoring, and Clinical Integration
Sponsored by: NCI Division of Cancer Treatment and Diagnosis (DCTD)
Date: September 23, 24, 25 (Tuesday-Thursday)
Time: 10am-2pm ET
Location: Microsoft Teams. 100% virtual
Overview
This workshop will bring together scientists, clinicians, engineers, patients, survivors, and advocates to explore cutting-edge microsystem technologies that are transforming cancer diagnostics, treatment monitoring, and disease management. Emphasizing transformative innovations, the workshop will highlight how microfluidics, lab-on-a-chip platforms, and other microscale technologies are advancing cancer research and personalized cancer care. The event will foster rigorous knowledge exchange, open scientific dialogue, and collaborative problem-solving focused on accelerating the translation of these technologies into clinical practice.
Objectives
- Discuss the latest innovations and emerging trends in microsystem applications for cancer diagnosis, monitoring treatment response, and management.
- Showcase real-world applications and advances in personalized and precision medicine enabled by microsystem technologies.
- Address challenges and opportunities in translating and implementing these technologies into clinical practice.
Workshop Planning Committee
- ** Co-Chairs (in alphabetical order):
- Rao Divi, Ph.D. (NCI)
- Miguel Ossandon, Ph.D. (NCI)
- Asif Rizwan*, Ph.D. (NCI)
- Brian Sorg, Ph.D. (NCI)
- ** Members (in alphabetical order):
- Lokesh Agrawal, Ph.D. (NCI)
- Leela Avula, Ph.D. (NCI)
- Jung Byun, Ph.D. (NCI)
- Jessica Falcone, Ph.D. (NIBIB)
- Piotr Grodzinski, Ph.D. (NCI)
- Christine Happel, Ph.D. (NCATS)
- Margaret Ochocinska, Ph.D. (NIH OD)
- Linda Zane, Ph.D. (NCI)
For meeting questions, contact:
Asif Rizwan, Ph.D.,
Program Director,
Diagnostic Biomarkers and Technology Branch,
Cancer Diagnosis Program
Division of Cancer Treatment and Diagnosis
National Cancer Institute
Email: asif.rizwan@nih.gov